The newest wrinkle-reducing prescription injectable to obtain FDA approval, Jeuveau, is a neurotoxin used to inject into the facial muscles of adults to temporarily reduce the appearance of moderate to severe frown lines between the eyebrows (glabellar lines or “elevens”). This alternative to Botox is also commonly used for “off-label” treatments (treatments for other uses other than what was approved by the FDA) of the brow lines, bunny lines (caused by scrunching the nose), chin wrinkles, crow’s feet, lip lines, a gummy smile, and neck bands. When injected, Jeuveau, a neuromodulator, works by relaxing the nerves that signal facial muscles to flex, thus temporarily smoothing out the appearance of wrinkles. Jeuveau lessens the appearance of current lines and helps prevent new lines from forming.
Made from the bacteria that causes botulism, Jeuveau is the purified form called prabotulinumtoxinA (BTX-A) or Botulinum toxin similar to Botox, used to block nerve activity that triggers facial muscle movement.